CLINICAL_TRIALS
trial_result
· 2011-08-16
Clinical Trial Update: Macugen Observational Study
Summary
Pfizer's Macugen (pegaptanib) observational study for age-related macular degeneration was terminated, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Vascular Endothelial Growth Factor, Macular Degeneration | Status: TERMINATED | Results posted: 2011-08-16